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The simian virus 40 (SV40) T antigen is composed of 708 amino acids and forms monomers and various 
oligomers and, in small amounts, heterologous complexes with the cellular oncoprotein p53 (T-~53). Using 
SV40 mutants coding for T antigen fragments which are either deleted in the N-terminal half or truncated 
by various lengths at the C-terminal end, we found that a region between amino acids 114 and 152 and 
a C-terminal region up to amino acid 669 are essential for the formation of high M, ohgomers of T antigen. 
Furthermore, only the C-terminal end up to amino acid 669 is essential for T-p53 complex formation but 
not the N-terminus up to amino acid 152. 
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1. INTRODUCTION 
The simian virus 40 large tumour antigen (SV40 
T antigen) is a multistructural protein which is in- 
volved in various steps in viral SV40 replication as 
well as SV40 cell transformation (reviews [1,2]). 
This protein is phosphorylated in multiple N- and 
C-terminal locations [3] and occurs structurally in 
different forms such as monomers (5 S) and 
various homologous oligomers (dimers, 7 S; 
tetramers, 16 S; higher oligomers, > 16 S) [4]. Fur- 
thermore, it forms heterologous complexes with 
the cellular protein ~53, called T-p53 (review [S]). 
Using different experimental approaches it has 
been shown that the oligomerization of T antigen 
seems to be somehow involved in viral DNA 
replication [6,7] but not in the maintenance of cell 
transformation [8]. On the other hand, the T-p53 
complexes may be necessary but are certainly not 
alone sufficient for the maintenance of cell 
transformation [8]. 
the oligomerization and T-p53 complex formation. 
It has been reported that phosphorylation of T an- 
tigen increases with its oligomerization 19,101. In 
our hands, in vitro enzymatic dephosphorylation 
of T antigen up to 80-90% does not result in the 
disaggregation of T antigen oligomers [ 111. Our re- 
cent data indicate different pathways for T antigen 
oligomerization and T-p53 complex formation [7]. 
Here, using fragments of large T obtained from 
different mutants, we found two areas, one within 
the N-terminal half (114-152) and another area 
close to the C-terminal end up to amino acid 669 
which are essential for oligomerization. Further- 
more this truncated C-terminal end at up to amino 
acid 669 is essential for T-p53 complex formation, 
whereas the N-terminal region up to amino acid 
152 seems to be dispensable. 
2. MATERIALS AND METHODS 
2.1. Cells and viruses 
Little is known about distinct regions of the 708 
amino acid long T antigen which are essential for 
Ad2+D2 virus, originally obtained from Cl. Fey 
(University of Lausanne, Switzerland) was grown 
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on TC-7 monkey cells as described in [12]. Dele- 
tion mutants dl 1066 and dl 1061 were kindly 
donated by J. Pipas, Pittsburgh, PA, and grown in 
BSC-40 or COS-7 monkey cells, respectively, as 
described [13]. COS-7 cells are SV40 transformed 
monkey cells [14] and CTM cells are mouse cells 
transformed by CTSVl [ 151. PstI cells, a rat cell 
line transformed by the SV40 PstI A fragment, 
were kindly provided by A. Graessman, Berlin, 
Germany [16]. All cells were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 5% 
fetal calf serum. 
2.2. Infection, radiolabelling and extraction of 
cells 
Confluent monolayers of TC-7 cells (3-4 x 106) 
were infected with Ad2+D2 for 38 h and with 
dl 1066 and dl 1061 for 48 h. For radiolabelling 
virus mutant infected monkey cells or SV40 
transformed cells (4 x 106) were washed three 
times with methionine-free Dulbecco’s modified 
Eagle’s medium and then labelled for 2 h with 111 
X lo4 Bq (30&i) [35S]methionine (NEN, 
Dreieich). After labelling, cells were washed with 
phosphate-buffered saline, scraped off the plates, 
pelleted and lysed with 0.4 ml extraction buffer 
(0.5% Nonidet P40, 10 mM Tris-HCl, pH 9.0, 
0.1 M NaCl) [17]. 
2.3. Analysis of T antigen and T-p53 complexes 
Fractions of sucrose density gradients or extracts 
of labelled cells were analysed for T antigen or T- 
~53 complexes by immunoprecipitation with 
hamster SV40 tumour sera or monoclonal 
p53-antibodies, PAb 122. Immunoprecipitates 
were washed, electrophoresed on 10% SDS- 
polyacrylamide gels and fluorographed as de- 
scribed in [17,18]. 
3. RESULTS AND DISCUSSION 
In order to study certain N- and C-terminal 
areas of the polypeptide chain of T antigen which 
might be necessary for oligomerization we have 
analysed different fragments of T antigen by 
sucrose density centrifugation. Monkey cells in- 
fected by various SV40 mutants or SV40 
transformed monkey, rat or mouse cells were 
labelled with [35S]methionine for 2 h, extracted 
and subjected to 5-20070 sucrose density gradients 
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as described in [ 17,18,19]. Fractions of each gra- 
dient were immunoprecipitated with hamster SV40 
tumour serum and the immunoprecipitates were 
run on 10% SDS-polyacrylamide gels. Fig.lA 
shows a typical sedimentation profile of wild-type 
T antigen from SV40 transformed monkey cells 
(COS-7) which sediments predominantly in two 
peaks, one around 5-7 S (mono- and dimers), a 
second one around 16 S (tetramers) and beyond 
[4,6]. Fig.lB displays the sedimentation profile of 
the DZ-protein which is a T antigen related hybrid 
protein encoded by the adenovirus 2-SV40 hybrid 
virus Ad2+D2 [20]. Instead of the original 114 N- 
terminal amino acids of T antigen this hybrid pro- 
tein contains an Ad2 encoded polypeptide 
(33 kDa) [20]. Thus, this hybrid D2-protein con- 
tains amino acids 115-708 from wild-type T an- 
tigen. Similarly to intact wild-type T antigen, the 
D2-protein sediments in low-M, forms and 
numerous forms of oligomers sediment down to 
the bottom of the gradient. According to these 
data a major N-terminal region ranging from 
amino acid 1 to 114 appears to be dispensable for 
the formation of fast sedimenting oligomers of T 
antigen. This assumption is strongly supported by 
the observation that aggregates of the DZprotein 
are typically sensitive to treatment with 20 mM 
EDTA like wild-type T antigen [ 18,191. 
To amplify further the results obtained with the 
DZ-protein, we selected the deletion mutant 
CTSVl [21] which codes for T antigen lacking 
amino acids 1 lo-152 and overlaps the N-terminal 
defect of the DZprotein (l-l 14). To analyse T an- 
tigen encoded by CTSVl for oligomerization we 
used a CTSVl transformed mouse cell line CTM 
[15]. As seen in fig. 1C this deleted T antigen 
sediments predominantly between 5 and 14 S and 
fails to aggregate to 16 S and higher oligomers. 
Thus, the region between amino acid 110 and 152 
including the N-terminal phosphorylation sites Ser 
111, Ser 123 and Thr 124 [3] is obviously essential 
for the formation of 16 S and higher oligomers. 
To investigate the C-terminal region of T an- 
tigen for oligomerization we selected from a few 
deletion mutants known to be viable, the dl 1066 
mutant [13] and, additionally dl 1061 as a non- 
viable example [ 131. Extracts from monkey cells 
infected by dl 1066 or dl 1061 were analysed on 
sucrose density gradients. The profile of dl 1066 T 
antigen missing C-terminal amino acids 670-708 
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Fig. 1. Sedimentation profiles of T antigen characterized by various deletions in N- and C-terminal regions. Cells were 
labelled with [35S]methionine and extracts were analysed by S-200/o sucrose density gradient centrifugation. Fractions 
were immunoprecipitated with hamster SV40 tumour serum, run on 10% SDS-polyacrylamide gels and fluorographed 
as described [17]. Markers for gradient centrifugation were rRNAs (5 S, 16 S and 23 S). Only the sedimentation profiles 
of individual T antigen fragments are shown: (A) wild-type T antigen from COS-7 cells, M, 90000; (B) DZ-protein from 
Ad2+D2 infected monkey cells (TC-7), M, 107000; Ad 120K protein [12] is detected above the D2-T; (C) T antigen 
lacking amino acids 110-152 from CTSVl-transformed mouse cells CTM, M, 83000; (D) truncated dl 1066 encoded 
T antigen from infected TC-7 cells (amino acids l-669), M, 87000; (E) dl 1061 T antigen, M, 77000, analysed like (D); 
(F) truncated T antigen from PslI A transformed rat cells (amino acids l-538), M, 80000. For details see section 2. 
53 
Volume 204, number 1 FEBS LETTERS August 1986 
(fig.lD) presents low- and high-M, forms which 
sediment in a broad distribution over the entire 
gradient. Aggregates edimenting around 16 S and 
beyond are sensitive to EDTA treatment like the 
DZprotein and wild-type T antigen (not shown) 
[ 18,191. This suggests that dl 1066 T antigen 
fulfills requirements for native oligomerization of 
wild-type T antigen. In contrast, T antigen en- 
coded by the nonviable dl 1061 mutant, lacking 
amino acids 591-708, fails to oligomerize to 16 S 
and higher aggregated forms (fig.lE) and the pro- 
file is not influenced by treatment with EDTA (not 
shown). An even shorter truncated T antigen from 
rat cells transformed by the P&I A fragment of 
SV40 DNA [16] lacking amino acids 539-708 is 
also unable to oligomerize (fig.lF) like dl 1061 T 
antigen. 
According to these results we can conclude that 
the native C-terminal area between amino acid 669 
and 708 is not involved in oligomerization. 
However, extension of this truncation upstream to 
amino acid 591 destroys this function. Conse- 
quently the phosphorylated residues Ser 676, Ser 




677, Ser 679 and Thr 701 [3] are also negligible for 
this mechanism. Taking these results together, one 
can postulate that both a C-terminal region be- 
tween amino acid 591 and 669 and an N-terminal 
region in the second exon between amino acid 115 
and 152 are essential for the formation of highly 
oligomeric forms. 
In previous experiments, we and others have 
shown that in SV40 infected and transformed cells, 
~53 is mostly found in high-M, T-p53 complexes 
[8,9]. One might speculate that the oligomerization 
of T antigen may be somehow involved in the pro- 
cess of T-p53 complex formation. Therefore we 
addressed the question of whether a truncated T 
antigen which is unable to aggregate into 16 S 
oligomers and higher aggregates might also be 
defective in binding to ~53. We tested the 
oligomerization-defective dl 1061 T antigen and, 
as a control, again the dl 1066 T antigen for the 
formation of T-~53. On the other hand, since the 
DZprotein missing amino acids l-l 14 is able to 
bind ~53 [22] we analysed CTSVl T antigen lack- 
ing amino acids 1 lo- 152 for complexing ~53. Cells 
ab c a b c a b c 
Fig.2. Sequential immunoprecipitation of T-p53 complexes and free T antigen from COS-7 cells (A), dl 1066 (B) and 
dl 1061 (C) infected monkey cells and CTSVl transformed mouse CTM cells (D). In each case approx. 4 x lo6 cells 
were labelled with [35S]methionine and cell extracts were incubated first with normal hamster serum (lane a) followed 
by PAb 122 (lane b) to precipitate ~53 and T-p53 complexes. The final supernatants were analysed for free T antigen 
by incubation with hamster SV40 tumour serum (lane c). Immunoprecipitates were electrophoresed and fluorographed 
on 10% SDS-polyacrylamide gels. Markers are indicated on the left: phosphorylase a (94 kDa), bovine serum albumin 
(68 kDa) and ovalbumin (43 kDa). T antigen and ~53 are indicated by arrowheads on the right. 
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were labelled with [3’S]methionine for 2 h and 
lysed as described in section 2. To detect T-p53 
complexes, extracts were first treated with the 
monoclonal antibody PAb 122 directed against 
~53 [23]. Free T antigen was immunoprecipitated 
from the supernatant with hamster SV4d tumour 
serum. The controls, native T-p53 complexes (lane 
b) and free T antigen (lane c) from COS-7 cells are 
shown in fig.2A. As expected, T antigen encoded 
by viable dl 1066 forms stable complexes with ~53 
(fig.2B, lane b) whereas dl 1061 T antigen which is 
defective for oligomerization is also unable to bind 
~53 (fig.2C, lane b). In contrast, we detected ~53 
stably complexed with the N-terminally deleted 
CTSVl T antigen in extracts of CTM cells (fig.2D, 
lane b). In all cases considerable amounts of free 
T antigen were found in the supernatants 
(fig.2A-D, lanes c). 
The combined data obtained with the 
Da-protein and CTSVl T antigen show that a ma- 
jor N-terminal region of amino acids I-152 is not 
critical for T-p53 complex formation. Since 
CTSVl T antigen from CTM cells is defective for 
the formation of tetramers (16 S) and higher 
oligomers this process can be excluded as a prere- 
quisite for T-p53 complex formation. Further- 
more, this observation confirms our recent results 
showing that T antigen encoded by tsA1499 is 
heat-sensitive for oligomerization but not for com- 
plex formation with ~53 [7,8]. The deletion of this 
mutant from amino acid 635 to 661 includes 
phosphorylated Ser 639 [3,24]. Since tsA1499 T 
antigen can oligomerize into high-h/i, aggregates 
and complex ~53 [7,8] we can narrow down the 
above-mentioned C-terminal (591-669) region 
necessary for oligomerization and T-p53 complex 
formation to amino acids 591-634. According to 
these deletions, we can exclude all five known C- 
terminal phosphorylation sites as having a func- 
tional role in oligomerization as well as in T-p53 
complex formation. The potential influence of in- 
dividual N-terminal phosphorylation sites on the 
oligomerization of T antigen needs to be 
determined. 
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